Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy

Ann Hematol. 2006 Sep;85(9):591-5. doi: 10.1007/s00277-006-0143-z. Epub 2006 Jun 10.

Abstract

Congenital dyserythropoietic anemia type I (CDA I) is a rare autosomal recessive disorder with ineffective erythropoiesis, characteristic morphological abnormalities of erythroblasts, and iron overloading. CDA I is caused by mutations in the CDAN I gene, encoding a protein named codanin-1. Complex bone abnormalities, especially syndactyly, have not been systematically described with this disease. We present two cases of morphologically and genetically confirmed CDA I with striking bone abnormalities and response to treatment with alpha-interferon. Our cases clearly document the association of skeletal anomalism with CDA I and indicate that codanin-1 may play a role in the development of the skeleton.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Adult
  • Alleles*
  • Anemia, Dyserythropoietic, Congenital / drug therapy
  • Anemia, Dyserythropoietic, Congenital / genetics*
  • Anemia, Dyserythropoietic, Congenital / pathology
  • Erythroblasts / pathology
  • Erythropoiesis / drug effects
  • Erythropoiesis / genetics*
  • Female
  • Foot Deformities, Congenital / drug therapy
  • Foot Deformities, Congenital / genetics*
  • Foot Deformities, Congenital / pathology
  • Glycoproteins / genetics*
  • Humans
  • Immunologic Factors / therapeutic use
  • Interferon-alpha / therapeutic use
  • Iron Overload / drug therapy
  • Iron Overload / genetics*
  • Iron Overload / pathology
  • Male
  • Middle Aged
  • Nuclear Proteins

Substances

  • CDAN1 protein, human
  • Glycoproteins
  • Immunologic Factors
  • Interferon-alpha
  • Nuclear Proteins